000 03599nam a22005775i 4500
999 _c200457015
_d75227
003 DE-He213
005 20231109085739.0
007 cr nn 008mamaa
008 221022s2022 sz | s |||| 0|eng d
020 _a9783031100901
024 7 _a10.1007/978-3-031-10090-1
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 0 0 _aQZ 241
072 7 _aMMP
_2bicssc
072 7 _aMED008000
_2bisacsh
072 7 _aMKS
_2thema
096 _aQZ241EBK
245 1 0 _aArtificial Intelligence in PET/CT Oncologic Imaging
_h[electronic resource] /
_cedited by John A. Andreou, Paris A. Kosmidis, Athanasios D. Gouliamos.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. Introduction : Artificial intelligence (AI) systems for Oncology -- 2. PET in Bone and Soft tissue tumors -- 3. (CNS) PET/CT: current AI applications -- 4. PET/CT findings in Head and Neck Cancer, current AI applications -- 5. PET/CT in Lung cancer, current AI applications -- 6. Breast cancer: PET/CT imaging, AI applications -- 7. PET/CT in Gynecologic cancer, current AI applications -- 8. PET/CT in Rectal cancer, current AI applications -- 9. PET/CT in Neuroendocrine tumors, current AI applications -- 10. PET/CT in the evaluation of Adrenal gland mass -- 11. PET/CT in Renal cancer -- 12. PET/CT in Testicular cancer -- 13. PET/CT in Prostate cancer -- 14. PET/CT in Malignant Lymphomas.
520 _aThis book presents artificial intelligence applications that may help in detecting disease, defining tissue characterization (benign vs malignant), staging and correlation with molecular biomarkers. Originally positioned as a means for noninvasive molecular phenotyping and quantification in the 1970s, PET's technological improvements in the 2000s generated renewed interest in quantification, which has grown over the last five years. This progress is parallel with the development of Artificial intelligence (AI) systems for Oncology which aim at providing the best possible treatment to patients suffering from lung, breast, brain, prostate, liver and other types of cancer. The chapters provide an overview of the use of AI in PET/CT imaging for various types of cancer, and it will be an invaluable tool especially for nuclear medicine physicians and oncologists.
650 0 _aRadiology.
650 0 _aNuclear medicine.
650 0 _aOncology.
650 0 _aComputer science.
650 1 4 _aRadiology.
650 2 4 _aNuclear Medicine.
650 2 4 _aOncology.
650 2 4 _aComputer Science.
653 0 _aNeoplasms -- diagnostic imaging
653 0 _aPositron Emission Tomography Computed Tomography
653 0 _aMedical Informatics Applications
653 0 _aArtificial Intelligence
700 1 _aAndreou, John A.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aKosmidis, Paris A.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aGouliamos, Athanasios D.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-031-10090-1
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng